We automated a kinetic procedure for determining amylase isoenzymes in serum and urine samples. We used 4-nitrophenylmaltoheptaoside as substrate and a selective amylase inhibitor with the Abbott-VP bichromatic system. By use of the maximum differences between pancreatic (P) and salivary (S) amylase activities remaining after inhibition by the selective inhibitor and by use of the linear range, a one-point standard method for calibration is proposed for determining amylase activities between about 50 and 1500 U/L when the P/S ratio exceeds 0.2. Results correlated well with those by electrophoresis and the Phadebas method (r = 0.99 for both pancreatic and salivary amylase). Reproducibilities (CV5) were 1.5% to 5.5% for pancreatic amylase and 1.4% to 3.3% for salivary amylase in serum, 0.8% to 2.0% for pancreatic amylase and 0.8% to 2.3% for salivary amylase in urine.
AdditIonal Keyphrases: urine synthetic substrates . bichromatic analysis . enzyme activity . reference interval for two age groups Two types of amylase (EC 3.2.1.1) isoenzymes have been reported in human serum, originating from pancreatic (P) and salivary (S) glands (1). Changes in the activity of these organ-specific amylases can reveal pancreatic and parotid disorders, so their separation is useful in the differential diagnosis of hyperamylasemia (2).
Recently, several synthetic substrates for amylase assay with kinetic methods have been reported, involving a coupled enzyme assay (3-9). Determination of isoamylase by an inhibition method with use of a defined substrate, as in the present method for separating amylase isoenzymes, has been performed by electrophoresis, a relatively time-consuming procedure that involves some overlap between the S-fraction and P-fraction (10, 11). A simpler, faster, automated kinetic method for determination of amylase isoenzymes is needed. We have adapted the original method of O'Donnell et al. (12) to a widely used enzyme-coupled determination of total amylase activity. The resulting procedure is relatively simple, is rapid, has a wide range of linearity, and can easily be adapted to an automated kinetic system.
Materials and Methods
Our adaptation involved the use of an Abbott-VP bichromatic discrete analyzer system (Abbott Laboratories, North Chicago, IL). The procedure (12) was readily adapted to this analyzer by using 10 LL of sample, flushing with buffer without the 50 .tL of inhibitor, and then adding 250 pL of amylase reagent after a 14-to 16-mm preincubation. Table  1 gives the instrument settings used in analyzing for total amylase and amylase isoenzymes, with 4-nitrophenylmaltoheptaoside as substrate, in the presence or absence of amylase inhibitor. Readings were taken 3 mm after the reaction was initiated. For the electrophoresis procedure we used the Helena Quick Scan Flur-Vis (Helena Labs, Beaumont, TX) and Titan ifi cellulose acetate; Blue Starch (Pharmacia) was used as the substrate for detecting amylase activities. The amylase assay reagent we used was obtained from Boehringer Mannheim Yamanouchi, Ltd., Japan, and the Phadebas selective-inhibition amylase kits were purchased from Shionogi Pharmaceutical Co., Ltd., Japan, and Pharmacia Japan, Ltd. Amylase inhibitors were purified from wheat germ, human pancreatic amylase (200 kU/g of protein), and human salivary amylase (35 kU/g of protein). We prepared a concentrated, lyophilized inhibitor reagent containing ammonium bicarbonate (30 mmol/L, pH 8.0) and 4 g of fattyacid-free bovine serum albumin per liter, according to the method of O'Donnell and McGeeney (13) .
Results
Dynamic range: Table 2 shows the inhibition rate of amylase isoenzymes and the calculation method for isoenzymes. Amylase activity in serum and urine was measured in the presence and absence of wheat-germ inhibitor. 2. SampleP-andS-amylaseactivity:P = (A -bT)I(a -b) andS = T -P whereI is total amylase activity(U/L), A is amylase activity (U/L) remaining afterinhibition (A, + R2), P is pancreatic amylase activity,andS is salivary amylase activity.
that obtained in standards, the activities of the two types of isoamylase can be calculated. Figure 1 shows the time course of the inhibitory reaction with amylase inhibitor. The aniylase activity in the absence of amylase inhibitor was expressed as 100%. After 10 to 15 mm, 80% of the purifIed S-amylase and 20% of the purified P-amylase were inhibited; 70% of total amylase activity in human serum was inhibited. Figure 2 shows the linearity of isoamylase activity after inhibition with amylase inhibitor. A standard curve can be prepared by mixing various proportions of P-and S-amylase and determining the respective activity of each in the presence or absence of amylase inhibitor. Figure 3 shows the amylase activityobtained by mixing solutions with known activities of F-and S-amylase in the presence of inhibitor. Total mixed isoamylase activities were expressed as 100% in the absence of inhibitor and were compared with the expected remaining 5-and P-amylase activities. Because the inhibition rate of amylase inhibitor was constant in solutions having total amylase activities between 50 and 1500 U/L with P/S ratio exceeding 0.2, a one-point calibration method by P/S standard isoamylase gave satisfactory results, even though the experimental and the theoretical values did not agree precisely.
Correlation: Figure 4 shows the correlation between isoamylase measurements by the proposed method, the electrophoretic method, and the Phadebas method. Comparison with electrophoresis and the Phadebas method yielded 0.99 as the correlation coefficient. Table 3 shows the between-run precision for serum and urinary isoamylases.
Precision:

Reference interval:
The reference values for serum isoamylase activity were obtained from data on 250 healthy adults under 59 years old and 515 healthy persons over 60 years old. Total, 5-, and P-amylase activities were 135 (SD 20), 76 (SD 16), and 54 (SD 4) U/L in the younger adults, and 153 (SD 36), 103 (SD 33), and 51 (SD 9) UIL in the aged. The values for total, 5-, and P-amylase activity were significantly different by Student's t-test (p = 0.005) between younger adults and the aged.
Discussion
For serum samples determined in the Abbott-VP, amylase activity at longer incubation periods was not linearly related to absorbance differences for activity >1500 U/L or for each concentration of standard enzyme mixture that they examined, but with our method we did not obtain linearity at a lower or higher P/S ratio. The nonlinearity with a substantially lower P/S ratio may reflect the linearity observed for total amylase activity. A different inhibition rate for the two isoamylases would allow a greater degree of remaining activity by the method of calculation, and inhibition also depends on the relationship between the amount of inhibitor and the isoamylase activity in the sample. Hoek's report (15) on the problem of a linear standard curve for isoamylase determination by selective inhibition was helpful to us in developing this automated kinetic determination of isoamylase activity, although the principle of our method was different from his.
As for the reference range: both total and isoamylase activity in the serum was greater for the aged subjects. Thus, when isoamylase distribution is assessedas an index to pancreatic and salivary amylase disorders, the patient's age should be taken into account. However, a high activity does not mean that the value is always abnormal because the normal isoenzyme distribution is affected by genetic variation and may vary according to the eating habits of the patients, as described by Skude (16) and Bossuyt et al. (17) .
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